1 / 5
| Customization: | Available |
|---|---|
| Varieties: | Growth Promoting Medicine |
| Component: | Mineral |
GMP Factory Veterinary Medicine Buparvaquone Injection 5%
Each ml contains: Buparvaquone 50mg
For treatment of tick-transmitted theileriosis caused by intracellular protozoan parasites Theileria parva and T. annulata in cattle. Active against both schizont and piroplasm stages.



| DOSAGE AND ADMINISTRATION | For intramuscular injection: 1 ml per 20 kg body weight. In severe cases, repeat within 48-72 hours. Do not exceed 10 ml per site. |
| ADVERSE REACTION | Localized, painless, oedematous swelling may occasionally occur at the injection site. |
| WITHDRAWAL PERIOD | Meat: 42 days | Milk: 2 days |
| STORAGE | Store dark and below 25°C. Do not freeze. Keep out of reach of children. |
| SHELF LIFE | 3 Years |
One-time high score passed the acceptance of eight veterinary drug GMP production lines. Production involves powder, premix, sterilized small and large volume injections, oral solutions, and traditional Chinese medicine extractions.


SJ medical